The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.

“Using the virus as a tool to understand how chromatin can be altered can open up new research into understanding the complexities of our own genome.” Cosma says that the interplay between DNA’s ...

New research uses bird droppings to track avian flu in remote regions, revealing hidden hotspots and potential for early ...

The importance of global influenza surveillance using simple and rapid diagnostics has been frequently highlighted. For influenza type B, the need exists for discrimination between the two currently ...

Contained within this matrix shell is the viral RNA genome, which (for influenza A viruses) consists of eight single-stranded, negative-sense RNA segments (negative-sense refers to the genome ...

The letter, signed by 79 medical societies, expresses concern over recent federal immunization review policies and asks that ...